GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome everyone to the GeoVax Third Quarter 2024 Corporate Update Call. My name is Michelle and I will facilitate today’s call.
Geovax Labs Inc. (GOVX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 266,000 | $641,060 | 0% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.95 | 8,000 | Officer, Director | 26,661 | 2024-08-09 | Filing | |
| $2.27 | 8,209 | Officer, Director | 18,661 | 2024-02-22 | Filing | |
| $2.15 | 520 | Officer, Director | 10,452 | 2024-02-21 | Filing | |
| $2.77 | 2,000 | Officer | 7,213 | 2024-02-07 | Filing | |
| $0.36 | 6,944 | Officer | 35,782 | 2023-12-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.14 | 50,000 | Large Shareholder | 231,070,253 | 2010-01-27 | Filing | |
| $0.14 | 40,000 | Large Shareholder | 231,120,253 | 2010-01-26 | Filing | |
| $0.14 | 35,000 | Large Shareholder | 231,160,253 | 2010-01-25 | Filing | |
| $0.15 | 25,000 | Large Shareholder | 231,195,253 | 2010-01-21 | Filing | |
| $0.15 | 25,000 | Large Shareholder | 231,220,253 | 2010-01-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 48,562.866,666,667 | $262,968 | 0% | |
| 2. | 27,562.933,333,333 | $149,253 | 0% | |
| 3. | 11,526.333,333,333 | $62,432 | 0% | |
| 4. | 6,529.4,666,666,667 | $35,357 | 0% | |
| 5. | 2,280.9,333,333,333 | $12,351 | 0% |
News See All
GeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome everyone to the GeoVax First Quarter 2024 Corporate Update Call. My name is Mark, and I will facilitate today's call.
GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome, everyone, to the GeoVax Fourth Quarter 2023 Corporate Update Call. My name is Desiree, and I will facilitate today's call.
GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome everyone to the GeoVax Third Quarter 2023 Corporate Update Call. My name is Mandeep and I will facilitate today's call.
GeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2023 Earnings Call Transcript
Operator: Good day. My name is Jordan and I will be your conference operator today. At this time I would like to welcome everyone to the GeoVax Second Quarter Earnings Conference Call.
GeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and welcome everyone to the GeoVax First Quarter 2023 Corporate Update Call. My name is Jack and I will facilitate today’s call.
GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome everyone to the GeoVax Fourth Quarter and Full Year 2022 Corporate Update Call. My name is Diego and I will facilitate today's call.
10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat.
10 Best Biotech Stocks Under $5
The biotech industry has seen strong growth in terms of funding through venture capitalists, joint ventures, and co-developments in the recent past.
10 Best Biotech Stocks Under $6 in 2021
In this article we will take a look at the 10 best biotech stocks under $6 in 2021.
Billionaire Hedge Funds
